Blood pressure medication used in New York has been recalled because of a "foreign material" that can lead to some very serious health issues. Endo International announced that one of its companies, Par Pharmaceutical (Par), is expanding its voluntary recall of blood pressure medicine. Blood Pre...
Quinapril and hydrochlorothiazide are used to treat hypertension, or high blood pressure. Two lots of Aurobindo's 20 mg/12.5 mg are included in the recall, both with expiration dates through January 2023, and the specific lot numbers can be found in the recallannouncementon Oct. 25. The tabl...
This is the latest in a string of recalls for blood pressure medications since last summer. Drug companies have recalled hundreds of lots of the blood pressure-lowering medications valsartan, losartan and irbesartan either alone or in combination with other drugs. Trace amounts of other cancer-caus...
Torrent Pharmaceuticals is expanding a recall of blood-pressure medication possibly tainted with a cancer-causing chemical. The expansion is the fifth by Torrent involving widely used losartan potassium tablets sold nationwide at retailers including Walmart. Regulators first moved to pull heart drugs with...
If you’re taking a blood pressure medication that was recently recalled, do not stop taking it. The FDA says that “the risk of harm to someone’s health may be higher if one of these medications is stopped immediately without any alternative treatment.” So, if...
https://www.health.harvard.edu/heart-health/meditation-and-a-relaxation-technique-to-lower-blood-pressure https://nypost.com/2023/09/15/how-to-lower-your-blood-pressure-without-medication-experts/ Make sure you try all of the online activities for this reading and listening - There are dictat...
Medication adherence Medication adherence was assessed with the Hill-Bone Compliance to High Blood Pressure Therapy Scale (HB-HBP) medication adherence subscale. The sub- scale has nine items with a four-point Likert-type scale: "none of the time," "some of the time," "most of the time,"...
Secondly, we did not have data on inotrope and/or vasopressor medication use in this dataset, which can have a significant impact on BPV. Future work in this field should include how BPV is mediated by inotropes and vasopressor therapy and its impact on postoperative outcomes. In addition, un...
Satjit Bhusri, a heart specialist at Lenox Hill Hospital in New York City, told HealthDay when the recall was first announced. "There are many other substitutes for this medication, and that is an important discussion all patients should have with their physician," Bhusri said. The FDA did ...
However, even with adjustment there is a remaining concern in cross-sectional and case-control studies that the disease process itself may have altered the levels of CV risk factors such as blood pressure and serum cholesterol levels, thereby masking much of the confounding effects of these ...